UNSPSC 51283912: Sulfafurazole or sulfisoxazole or sulphafurazole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H13N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 740T4C525W, chemically known as 3,4-dimethylisoxazole-5-sulphanilamide but generally known as sulfafurazole, which bears US NIH Compound Identifier 5344. European Medicines Agency schedules Sulfafurazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10702MIG.

World Health Organization schedules sulfafurazole in its Anatomical Therapeutic Chemical (ATC) Classification. SULFAFURAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N.

UNSPSC 51283912 Sulfafurazole or sulfisoxazole or sulphafurazole is a Commodity code that nominally describes a specific antibiotic pharmaceutical product, but recent state and local solicitations show minimal or no procurement activity actually matching this narrow drug specification. The most recent opportunities in the source are tagged to this code yet involve unrelated pharmaceutical products — one a completed piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, the other a Seminole County, Florida procurement for Naloxone and drug deactivation systems. Neither represents demand for sulfafurazole or its chemical variants. State and local procurement records appear to misclassify these opportunities or use this code as a general pharmaceutical catch-all rather than a specific product line. Issuing bodies active in the recent record include state health departments (Illinois Department of Public Health) and county health or public-safety agencies (Seminole County), but the pharmaceutical products named do not align with the code's intended scope.

The code shows little decision-relevant recent activity for firms seeking work under its actual product definition. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract to Chartwell Rx LLC (Invitation for Bid, award date August 28, 2026) for antibiotic tablets through the MMCAP Infuse consortium, and Seminole County posted an IFB (response deadline July 26, 2023) for emergency-response pharmaceuticals, but neither procurement relates to sulfafurazole or sulfisoxazole. Firms targeting this code should verify whether state and local procurement offices have separate, correctly classified codes for this specific antibiotic class or whether opportunities under this code continue to reflect misclassified non-matching products.